February 2014

 

Mitodys Logo Canvas

 

Who?

MitoDys is a drug-discovery platform, working on a novel approach to treating Parkinson's disease.

MitoDys is headed up by founder Steven Zimmer and a world-class board of scientific and clinical advisors led by Dr David Weiner, a clinician scientist who is a noted expert in Parkinson’s disease, along with a network of academic laboratories and partner CROs.

 

Mito Dys Theraputics Canvas

 

How Much?

MitoDys hit their target and raised £150,000

 

Who invested?

The Life Neurological Research Trust, two business angels and SyndicateRoom members.

 

Why?

To fund the initial optimisation and validation of MitoDys’ discovery platform through initial drug prototypes.

Take a look at MitoDys website to find out the latest news: www.mitodys.com